Roberto Mignone, Director at TEVA PHARMACEUTICAL INDUSTRIES LTD (TEVA), sold 519,000 shares at $17.03 ($8.8M) on 2024-06-18, disclosed to the SEC on 2024-06-21.
Seasonal sale ($8.8M) by Director — this insider has traded TEVA in June in at least three consecutive prior years. Pattern-driven, low signal.
Negative factors outweigh the positive ones.
| Filing → |
| TEVA | SELL | 2025-12-01 | $1.3M | — | Filing → |
| TEVA | SELL | 2025-11-10 | $4.8M | — | Filing → |
| TEVA | SELL | 2024-12-26 | $6.3M | — | Filing → |